Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

InMed Pharmaceuticals (INM) Non-Current Assets (2021 - 2025)

Historic Non-Current Assets for InMed Pharmaceuticals (INM) over the last 5 years, with Q4 2025 value amounting to $2.4 million.

  • InMed Pharmaceuticals' Non-Current Assets fell 2075.55% to $2.4 million in Q4 2025 from the same period last year, while for Dec 2025 it was $10.5 million, marking a year-over-year decrease of 1659.76%. This contributed to the annual value of $2.7 million for FY2025, which is 1341.88% down from last year.
  • As of Q4 2025, InMed Pharmaceuticals' Non-Current Assets stood at $2.4 million, which was down 2075.55% from $2.6 million recorded in Q3 2025.
  • InMed Pharmaceuticals' 5-year Non-Current Assets high stood at $6.9 million for Q4 2021, and its period low was $1.4 million during Q3 2021.
  • Over the past 5 years, InMed Pharmaceuticals' median Non-Current Assets value was $3.0 million (recorded in 2022), while the average stood at $3.3 million.
  • Data for InMed Pharmaceuticals' Non-Current Assets shows a peak YoY increase of 12513.35% (in 2022) and a maximum YoY decrease of 5781.2% (in 2022) over the last 5 years.
  • Quarter analysis of 5 years shows InMed Pharmaceuticals' Non-Current Assets stood at $6.9 million in 2021, then tumbled by 57.81% to $2.9 million in 2022, then grew by 18.73% to $3.4 million in 2023, then fell by 11.99% to $3.0 million in 2024, then fell by 20.76% to $2.4 million in 2025.
  • Its Non-Current Assets stands at $2.4 million for Q4 2025, versus $2.6 million for Q3 2025 and $2.7 million for Q2 2025.